Navigation Links
Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007
Date:11/6/2007

of disease-related molecules (antigens) of foreign or self origin that is capable of activating the immune system against such antigens with the goal to modulate disease processes.

This foregoing press release may contain forward-looking statements that include words or phrases such as "designed", "potential", "would", "should", "could", "promising", "suggest", "aim", "intend" or other similar expressions. These forward-looking statements are subject to a variety of significant uncertainties, including scientific, business, economic and financial factors, and therefore actual results may differ significantly from those presented. There can be no assurance that any other therapeutic entities will enter clinical trials, that clinical trial results will be predictive for future results, that therapeutic entities will be the subject of filings for regulatory approval, that any drug candidates will receive marketing approval from the U.S. Food and Drug Administration or equivalent regulatory authorities, or that drugs will be marketed successfully. Against the background of these uncertainties readers should not rely on forward-looking statements. The company assumes no responsibility to update forward-looking statements or adapt them to future events or developments. This document does not constitute an offer or invitation to subscribe or purchase any securities of Cytos Biotechnology AG.

For further information please contact:

Claudine Blaser, PhD

Director Corporate Communications

Cytos Biotechnology AG, Wagistrasse 25, CH-8952 Schlieren,

Switzerland

Phone: +41-44-733-47-20,

e-Mail: claudine.blaser@cytos.com,

Website: http://www.cytos.com


'/>"/>
SOURCE Cytos Biotechnology AG
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Strategic Diagnostics Updates Roth Conference Presentation Time
2. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
3. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation
4. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
5. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
8. Volcano Corporation Presentation at Bear Stearns Conference to be Webcast
9. Telik Announces Presentation and Webcast at Bear Stearns Healthcare Conference
10. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
11. ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2015)... May 25, 2015 Phenome Networks, ... provider, announced the availability, beginning May 31st, of its ... of Phenome One solidifies Phenome Networks’ lead in the ... a simple and intuitive breeding workflow based on years ... to customize field design, and more. The new version ...
(Date:5/22/2015)... NJ (PRWEB) May 22, 2015 ... new white paper that explores the potential of big ... The white paper was developed to help life sciences ... can leverage data to gain critical business insights. , ... large amounts of data driven by patient profiling, compliance ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Specialty ... audit and been admitted to BPA Worldwide as ... Worldwide will track audience data for Specialty Pharmacy ... , “By becoming a member of BPA ... to providing our clients with the most reliable, ...
(Date:5/21/2015)... May 21, 2015  The EveryLife Foundation for ... (R-UT) and Amy Klobuchar (D-MN) today ... Cures & Treatments, or OPEN ACT. ... advocacy organizations, this bipartisan legislation promises to rapidly ... to rare disease patients by incentivizing drug makers ...
Breaking Biology Technology:Phenome Networks Announces its Next Generation Plant Breeding Management and Analytics Software 2Phenome Networks Announces its Next Generation Plant Breeding Management and Analytics Software 3New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2Specialty Pharmacy Times Joins BPA Worldwide 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2
... (Nasdaq: NBIX ) announced today that Kevin Gorman, ... Chief Executive,Officer and a member of the Board of ... President and Chief Executive Officer of,Neurocrine and will continue ... "While this was a very difficult decision for ...
... 14 VIRxSYS Corporation, a,privately held company developing ... Corporation, a privately-owned biotechnology company,focused on the manufacture ... have agreed to settle the pending litigation between,the ... and counterclaims,asserted in the lawsuit, which has been ...
... Patients are ... in the U.S., REHOVOT, Israel and NORTH BRUNSWICK, ... ROSG ), a leader,in the development of microRNA-based diagnostics ... with the Henry Ford,Health System in Detroit, Michigan, to ...
Cached Biology Technology:Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer 2VIRxSYS and Lentigen Announce Litigation Settlement 2Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer 2Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer 3Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer 4
(Date:5/20/2015)... OXFORD, Conn. , May 20, 2015 ... "Company") announces that its wholly owned subsidiary, 3D-ID LLC, ... contractor under Team Battelle for the biometrics technology portion ... Unrestricted Suite Contract from the Department of the Army. ... facial recognition products developed for government, law enforcement and ...
(Date:5/18/2015)... , May 18, 2015 Fingerprint Cards ... FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from one if its ... until and including Q3 2015 and the sensors will be ... Communicated order values for 2015 hereby amount to 740 MSEK ... 2015 of 140 MSEK and a number of smaller orders ...
(Date:5/11/2015)... DAYTON, Ohio , May 11, 2015  Through a ... Ohio had a strong showing at AUVSI,s ... . These representatives of Ohio,s UAS ... domestic and abroad from all points along the UAS ecosystem. ... Dayton Development Coalition,s (DDC) Vice President for Aerospace Rich ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... science and engineering, a National Science Foundation (NSF)-funded research ... of Antarctic ice to reach a subglacial lake and ... from direct contact with the atmosphere for many thousands ... interdisciplinary Whillans Ice Stream Subglacial Access Research Drilling project ...
... Nathan Nelson of Tel Aviv University,s Department of Biochemistry ... awarded the 2012 Israel Prize in the field of ... on the eve of Israel,s Independence Day in April ... Prof. Nelson is internationally renowned for his research into ...
... science is a comprehensive understanding of the human brain ... technologies in information and communication. In a major announcement ... the Okinawa Institute of Science and Technology Graduate University ... European consortium on the Human Brain Project (HBP), which ...
Cached Biology News:NSF-funded team samples Antarctic lake beneath the ice sheet 2NSF-funded team samples Antarctic lake beneath the ice sheet 3Japanese research organizations contribute to Human Brain Project 2Japanese research organizations contribute to Human Brain Project 3
Anti-Mouse Valpha 2 TCR, Purified (Clone B20.1) (rat IgG2a)...
Recombinant Feline IFN-alpha...
... contains the basic components required for the ... and recombinant canine Monocyte Chemotactic Protein 1 ... Each kit contains sufficient materials to run ... that the following conditions are met:2 ...
ROCK-1 (cleaved) Monoclonal Ab 100 ug purified mouse monoclonal antibody. Clone# 12M03. Reacts with human. Tested in Western blot analysis....
Biology Products: